Developing Diagnostic Tools for Feline Infectious Peritonitis (FIP)
Researchers will investigate whether viral mutations associated with feline infectious peritonitis are valuable and effective diagnostic targets.
Researchers will investigate whether viral mutations associated with feline infectious peritonitis are valuable and effective diagnostic targets.
Researchers will investigate a vaccine strategy against feline enteric coronavirus, a common, nonlethal virus that can mutate into feline infectious peritonitis virus.
Researchers will investigate genetic changes that occur in the feline enteric coronavirus that contribute to the development of feline infectious peritonitis, an incurable and fatal disease in cats.
Researchers will conduct a clinical trial to investigate the effectiveness of a novel antiviral drug in client-owned cats with naturally occurring feline infectious peritonitis as well as drug resistance that may occur during treatment.
Researchers will improve the quality of the feline genome assembly, an important tool for studying genetic causes and risks associated with diseases in cats.
Researchers will investigate the effectiveness of a new anticoagulant drug to prevent abnormal and deadly blood clotting complications in cats with heart disease.
Researchers will investigate the effectiveness of the antiviral drug famciclovir to treat and control infectious upper-respiratory disease associated with feline herpesvirus in shelter cats.